Dr. Electron Kebebew, MD

Dr. Kebebew practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Kebebew's NPI, 1972567246, was assigned on April 13, 2006. Dr. Kebebew graduated from UCSF School of Medicine in 1995. Dr. Kebebew holds California license A62307.

Dr. Kebebew's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Kebebew's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Dr. Kebebew is also affiliated with Stanford Health Care Tri-Valley. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Kebebew to 2 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account. Dr. Kebebew's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kebebew practices, 6 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Kebebew's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Kebebew is board certified in surgery by the American Board of Surgery. Dr. Kebebew is licensed in California.

Dmand AI lists thyroid surgery among the conditions Dr. Kebebew treats.

CMS data shows 234 Medicare services from Dr. Kebebew across 9 procedure codes in 2024, for 116 Medicare patients. Medicare paid $56,713 for them.

CMS counts 116 Medicare patients who saw Dr. Kebebew in 2026. The largest group is 65 to 74, with 65 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 17% are also on Medicaid. Their average risk score is 1.46, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kebebew's median patient age at 58, with 66% women.

In 2026, Dr. Kebebew wrote 59 Medicare Part D claims for 33 patients. 80% of them were for generic drugs. CMS names the drug for 18 of them, across 1 drug with 11 or more claims each, at $127 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Kebebew for performance year 2026, reported as part of a group. Dr. Kebebew accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kebebew as offering telehealth.

Dmand AI links 425 papers to Dr. Kebebew, published from 2006 to 2025. 2016 was the busiest year, with 32. The most frequent topics are Thyroid Neoplasms, Pancreatic Neoplasms and Neuroendocrine Tumors. Dr. Kebebew has published most often in Surgery. Dr. Kebebew's most frequent co-authors are Naris Nilubol, MD, Corina M. Millo, MD and Wen Tsong Shen, MD.

Dmand AI links Dr. Kebebew to 17 clinical trials, 7 of them phase 2 studies. 2 are still active or recruiting. Conditions studied include Thyroid Neoplasms, Adrenocortical Carcinoma and Head and Neck Neoplasms. National Cancer Institute (NCI) sponsors the most, 9.

CMS Open Payments shows 2 general payments to Dr. Kebebew from 2 drug and device companies from 2017 to 2024. Food and beverage make up the largest share, 100% of the total. Molnlycke Health Care US, LLC paid the most, $64.

Dmand AI lists 1 award for Dr. Kebebew.

Dr. Kebebew graduated from UCSF School of Medicine in 1995. Dr. Kebebew is a member of ACS.

Dr. Kebebew is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.